There are 6 papers on adverse drug event in aging research: 4 observational studies in people, 2 reviews.
6 papers study it58 more mention it
- Humans4
Trial sponsors
Company1 trialPhase 4238 people
2 trialsPhase 41,024 people
Beijing Shijitan Hospital, Capital Medical University
1 trialPhase 4306 people
1 trialPhase 440 people
1 trialPhase 3374 people
1 trialPhase 3300 people
Latest
11 papers in 12 monthsmedRxiv
Integrating Causal Inference into Pharmacovigilance: Target Trial Emulations for Proactive Signal Detection of Atorvastatin Initiation in Medicare Beneficiaries
Preprint: cohort study of 70,130 peopleAtorvastatin
Age and Ageing
Retrospective multi-centre cohort study of polypharmacy, the Drug Burden Index and associations with outcomes in older surgical inpatients
Cohort study of 13,815 peoplePopulations
Internal Medicine Journal
Prevalence of heart failure pharmacotherapy utilisation, frailty and adverse drug events among hospitalised adults older than 75 years: a multicentre cross-sectional study
Cross-sectional study of 2,000 peopleHeart failure
Therapeutic Advances in Drug Safety
Sex-specific risk factors for genital infections associated with SGLT2 inhibitors in type 2 diabetes: a retrospective cohort study and disproportionality analysis using JADER
Cohort study of 2,202 peopleGenital infections
International Journal of Pharmaceutical Quality Assurance
Polypharmacy and Healthcare Utilization Outcomes in Older Adults: A Retrospective Study
Cohort study of 192 peoplePopulations
Journal of Education Health and Sport
Effectiveness and safety of deprescribing interventions in older adults with polypharmacy: a review of clinical trials from 2017 to 2026
ReviewPolypharmacy
European Geriatric Medicine
Multimorbidity, polypharmacy and frailty in critically ill older adults
ReviewMultimorbidity
Nature Communications
Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes
Study in peopleInterventions
Frontiers in Medicine
Integrating pharmacovigilance signals with real-world validation: a study on neurological events associated with PCSK9 inhibitors
Study of 173,622 peoplePCSK9 inhibitors